Investing Profile

Vijay Pande

VCInvestor

General Partner at Andreessen Horowitz

a16z.com/author/vijay-pande/San Francisco, California

Your Intro Paths to Vijay Pande

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Vijay is a member of

Massachusetts Institute of Technology Network

112 CONNECTIONS

Princeton University Network

97 CONNECTIONS

Stanford University Network

69 CONNECTIONS

Stanford University Network

69 CONNECTIONS

Andreessen Horowitz Network

42 CONNECTIONS

Find Vijay Pande on

Current Investing Position

Andreessen Horowitz General Partner

Investment Range

$100K - $10.0M

Sweet Spot

$100K

Investments On Record

Current Fund Size

$2.2B

Vijay Pande is on these Sector & Stage Rankings

BioTech (Pre-Seed)BioTech (Seed)Digital Health (Pre-Seed)Digital Health (Seed)Health & Hospital Services (Pre-Seed)Health & Hospital Services (Seed)Health IT (Pre-Seed)Health IT (Seed)Pharmaceuticals (Pre-Seed)Pharmaceuticals (Seed)San Francisco Bay Area

Vijay Pande's Investments On Record (15)

Company	StageDateRound Size	Total Raised
SCiFi Foods	Series AJun 2022$22M	$22M
Co-investors: Andrew J Scott (7percent Ventures)
Levels	Series AApr 2022$38M Seed RoundNov 2020$12M	$58M
Co-investors: Jeff Jordan (Andreessen Horowitz), Marc Andreessen (Andreessen Horowitz), Micah Rosenbloom (Founder Collective), Lenny Rachitsky (AirAngels), Ben Gilbert (Pioneer Square Labs), Andrea Funsten (Basecamp Fund), Laurel Touby (Supernode Ventures), Michael Arrington (CrunchFund), Dick Costolo (01 Advisors), Omar Darwazah (AAF Management Ltd.), Rahul Vohra (Todd and Rahul's Angel Fund), Matthew Dellavedova, Brendan O'Driscoll, Mattia Astori, Mario Gabriele
Deepcell	Series BMar 2022$73M Series ADec 2020$20M	$93M
Co-investors: Matt Mcilwain (Madrona Ventures)
Devoted Health	Series DOct 2021$1.2B Series CApr 2020$450M Series BOct 2018$300M	$2B
Co-investors: Carl Byers (F-Prime Capital Partners), Ling Wong (Highbury Group)
Bayesian Health	Venture RoundJul 2021$15M	$15M
Co-investors: Julie Yoo (Andreessen Horowitz), Vineeta Agarwala (Andreessen Horowitz), R. Jacob Vogelstein (Catalio Capital)
Scribe Therapeutics	Series BMar 2021$100M Series AJan 2018$20M	$120M
Co-investors: Carl Gordon (OrbiMed)
Insitro	Series CMar 2021$400M Series BMay 2020$140M Series AMay 2018$100M	$740M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Jim Tananbaum (Foresite Capital), Robert Nelsen (ARCH Venture Partners), Jay Markowitz (ARCH Venture Partners)
Genesis Therapeutics	Series ADec 2020$52M Seed RoundNov 2019$4.1M	$56M
Co-investors: Greg Yap (Menlo Ventures), Miriam Rivera (Ulu Ventures), Clint Korver (Ulu Ventures), Bukola Ojo